Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
08/24 AstraZeneca names Genentech's Bohen as chief medical officer
08/19DJRoche Buys U.S. Gene-Technology Company Kapa Biosystems
08/17 ROCHE : Pivotal Phase II Study Showed Genentech’s Investigational Immunoth..
08/13 Roche buys 'superbug' diagnostics firm for up to $425 million
08/13DJRoche Buys U.S. Company GeneWEAVE BioSciences Inc.
08/12 ROCHE : Pivotal Phase II Study of Investigational Medicine Venetoclax Met Primar..
08/05 Shire seen having to sweeten $30 billion offer to win Baxalta
08/03 Analysis - New cocktails to test limits of cancer drug pricing
07/31DJROCHE : Gets EU Approval For Perjeta In Pre-Surgery Breast Cancer Treatment
07/23DJBristol-Myers Revenue Boosted by Cancer Drug Opdivo
07/23DJBristol-Myers Gets a Revenue Boost from Opdivo
07/23DJRoche Battered by Strong Swiss Franc -- Update
07/23DJRoche Battered by Strong Swiss Franc
07/23DJRoche Battered by Strong Swiss Franc
07/22DJLilly's Alzheimer's Drug May Slow Patients' Decline, Study Shows -- Update
07/20DJRoche Holding AG HY 2015 -- Forecast
07/16 Immunocore raises $320 million in record financing round
07/13DJRoche Says Drug Meets Bladder Cancer Target
07/13DJRoche Says Drug Meets Bladder Cancer Target
07/13 ROCHE : In a Pivotal Study, Genentech’s Investigational Immunotherapy Atez..
07/06 Drug companies still supplying Greece after 'No' vote
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
06/30 U.S. seeks up to $3.35 billion in Novartis kickback lawsuit
06/30DJROCHE : Announces Positive Results From Studies on Multiple Sclerosis Drug
06/30 ROCHE : Genentech :’s ocrelizumab Significantly Reduced Both Relapses and ..
06/29 Drugmakers warn Greek medicine supply 'may be in jeopardy'
06/19DJNOVARTIS CEO : Roche Stake Would No Longer Have to Be Sold at Premium
06/16 Energy and medicine top import risk list as Greece teeters
06/11 ROCHE : Ariosa receives CE mark for its FORTE Software to support Harmony™..
06/11 ROCHE : Ariosa grants licenses to laboratories to perform non-invasive prenatal ..
06/10 ROCHE : FDA Grants Breakthrough Therapy Designation for Actemra (tocilizumab) in..
06/10 Bayer sells Diabetes Care business to Panasonic Healthcare
06/10DJRoche Gains U.S. Breakthrough Therapy Designation for Actemra Drug
06/09 ROCHE : To Develop Companion Diagnostic Test For Acute Coronary Syndrome
06/01DJEuropean Shares Give Up Early Gains
06/01 ROCHE : Genentech :’s Perjeta Regimen Helped People with HER2-positive Ear..
05/30 ROCHE : Updated Data Showed Genentech’s Investigational Combination of Cob..
05/30 ROCHE : Genentech :’s Gazyva® Extended the Time People With Refractory Ind..
05/27 ROCHE : Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop..
05/15DJEUROPE MARKETS : European Stocks Erase Draghi-inspired Gains After Weak U.S. Dat..
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/15DJEUROPE MARKETS : European Stocks Build On Draghi-inspired Gains
05/13DJPharma Industry Needs Billions of Dollars for Antibiotics Research
05/13 ROCHE : Genentech :’s Investigational Immunotherapy MPDL3280A Doubled the ..
05/13 ROCHE : Genentech :’s Investigational Medicine Alectinib Shrank Tumors in ..
05/11 ROCHE : Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Pre..
05/08DJRoche Nominates Smith & Nephew CFO to Board of Directors
05/07DJFDA Grants Therapy Designation to Roche Leukemia Drug
05/05 Global cancer drug spending hits $100 billion in 2014 - IMS Health
05/04 ROCHE : Genentech : Announces New STEM Education Initiative to Support South San..
04/27DJIn Fight Against Alzheimer's, Roche Trial in Colombia Is Ground Zero
04/24 AstraZeneca insists Celgene deal about strategy, not cash
04/23DJZynga Chief Operating Officer Clive Downie Resigns
04/22DJEuropean Stocks End Flat as Greek Tensions Ease -- 3rd Update
04/22DJRoche Revenue Lifted by Cancer Drugs -- 2nd Update
04/22DJStocks Fall on Greek Eurozone Jitters -- Update
04/22DJEuropean Stocks Boosted by Asian Rally
04/22DJRoche Revenue Lifted by Cancer Drugs -- Update
04/22DJRoche Revenue Lifted by Cancer Drugs
04/22DJRoche Revenue Lifted by Cancer Drugs
04/22DJStocks Fall on Greek Eurozone Jitters
04/19DJMerck Drug Shows Improved Odds for Melanoma Patients--Update
04/19DJMerck's Keytruda Shows Improved Survival Odds for Melanoma Patients
04/17DJRoche Holding 1Q 2015 -- Forecast
04/15DJCorrection to 'Study Sparks Debate on Accuracy of Genome Tests' Article
04/15DJStudy Sparks Debate on Accuracy of Genome Tests for Cancer Patients
04/12DJHow the Hottest Biotech Sprouted in Iowa
04/08DJROCHE : European Regulators Approved Roche's Avastin for Cervical Cancer Treatme..
04/02 ROCHE BEARER SHARE : Ariosa's Harmony™ Prenatal Test shown to be superior ..
03/22 Currency hedging takes on new importance for global stock funds
03/19 ROCHE : Sigma-Aldrich : Announces Exclusive Distribution Agreement with Roche
03/12DJ23andMe to Use Genetic Database for Drug Discovery
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 4th Update
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 3rd Update
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | RHO5 | CH0012032048 | 4-Traders
Income Statement Evolution
More Financials